These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8510226)

  • 1. Vaccination to prevent persistent viral infection.
    Oldstone MB; Tishon A; Eddleston M; de la Torre JC; McKee T; Whitton JL
    J Virol; 1993 Jul; 67(7):4372-8. PubMed ID: 8510226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen.
    An LL; Whitton JL
    J Virol; 1997 Mar; 71(3):2292-302. PubMed ID: 9032365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes.
    Slifka MK; Shen H; Matloubian M; Jensen ER; Miller JF; Ahmed R
    J Virol; 1996 May; 70(5):2902-10. PubMed ID: 8627765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection.
    Klavinskis LS; Whitton JL; Oldstone MB
    J Virol; 1989 Oct; 63(10):4311-6. PubMed ID: 2476571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope.
    Klavinskis LS; Whitton JL; Joly E; Oldstone MB
    Virology; 1990 Oct; 178(2):393-400. PubMed ID: 1699348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
    Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice.
    van der Most RG; Murali-Krishna K; Whitton JL; Oseroff C; Alexander J; Southwood S; Sidney J; Chesnut RW; Sette A; Ahmed R
    Virology; 1998 Jan; 240(1):158-67. PubMed ID: 9448700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
    van der Most RG; Sette A; Oseroff C; Alexander J; Murali-Krishna K; Lau LL; Southwood S; Sidney J; Chesnut RW; Matloubian M; Ahmed R
    J Immunol; 1996 Dec; 157(12):5543-54. PubMed ID: 8955205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral protection after DNA vaccination is short lived and not enhanced by CpG DNA.
    Oehen S; Junt T; López-Macías C; Kramps TA
    Immunology; 2000 Feb; 99(2):163-9. PubMed ID: 10692032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.
    Storni T; Lechner F; Erdmann I; Bächi T; Jegerlehner A; Dumrese T; Kündig TM; Ruedl C; Bachmann MF
    J Immunol; 2002 Mar; 168(6):2880-6. PubMed ID: 11884458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus.
    Moskophidis D; Zinkernagel RM
    J Virol; 1995 Apr; 69(4):2187-93. PubMed ID: 7533851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge.
    Whitton JL; Sheng N; Oldstone MB; McKee TA
    J Virol; 1993 Jan; 67(1):348-52. PubMed ID: 7677954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common antiviral cytotoxic T-lymphocyte epitope for diverse major histocompatibility complex haplotypes: implications for vaccination.
    Oldstone MB; Tishon A; Geckeler R; Lewicki H; Whitton JL
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2752-5. PubMed ID: 1372990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.
    von Herrath MG; Yokoyama M; Dockter J; Oldstone MB; Whitton JL
    J Virol; 1996 Feb; 70(2):1072-9. PubMed ID: 8551565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination to treat persistent viral infection.
    von Herrath MG; Berger DP; Homann D; Tishon T; Sette A; Oldstone MB
    Virology; 2000 Mar; 268(2):411-9. PubMed ID: 10704349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein.
    Zarozinski CC; Fynan EF; Selin LK; Robinson HL; Welsh RM
    J Immunol; 1995 Apr; 154(8):4010-7. PubMed ID: 7706740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
    Selin LK; Nahill SR; Welsh RM
    J Exp Med; 1994 Jun; 179(6):1933-43. PubMed ID: 8195718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection.
    Borrow P; Tishon A; Oldstone MB
    J Exp Med; 1991 Jul; 174(1):203-12. PubMed ID: 1905339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes.
    Castrucci MR; Hou S; Doherty PC; Kawaoka Y
    J Virol; 1994 Jun; 68(6):3486-90. PubMed ID: 7514676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.